Upcoming Webinar Digestive Diseases | Metabolic Diseases 2020

Theme: Covid-19 Pandemic advancements in Digestive diseases

Digestive Diseases 2020

Renowned Speakers

Abdullah Abdulrahman Bin Salamah
King Saud University college of Medicine
Saudi Arabia

I Dewa Nyoman Wibawa
Fakultas Kedokteran Universitas Indonesia
Indonesia

Maxwell M Chait
Columbia UniversityÂ
USA

Mayson Abu Raya
Rappaport Faculty of MedicineÂ
Israel

Amanda J Brisebois
University of AlbertaÂ
Canada

Vijay Kumar
Manipal UniversityÂ
India

Yakovleva Inna
National Academy of Medical Sciences of Ukraine
Ukraine

Pawan Mathur
Colorectal & Laparoscopic Surgeon, Royal Free London NHS Fundation Trust.
UK

Andrew Vaillant
Replicor IncÂ
Canada

Andreas Christe
University Hospital of Bern
Switzerland

Jisoo Park
Chungnam National University
South Korea

Hussien Elsiesy
King Faisal Specialist Hospital & Research CenterÂ
Saudi Arabia

ESCHLIMANN Marine
Lorraine UniversityÂ
France

Arnolfo Petruzziello
National Cancer InstituteÂ
Italy

Ligita Jancoriene
Vilnius University Hospital
Lithuania

Bertrand Geier
Centre University Hospital of Brest 29200Â
France

Edmundo Dedias
President CEPCEAÂ
Peru

Jian Guan
Peking Union Medical CollegeÂ
China

Prapan Jutavijittum
Chiang Mai UniversityÂ
Thailand

Quintin H. Gonzalez
Colorectal SurgeonÂ
Mexico

Joseph Payne
Arcturus TherapeuticsÂ
USA

Rasha Hatem Saeed Dosh
Sheffield Hallam UniversityÂ
UK

Trent W Nichols
AMRI
USA

Alina Voinic
Vilnius UniversityÂ
Lithuania

Jolanta Zaikauskiene
Abbvie Pharmaceutical CompanyÂ
Lithuania

AndrÃ©-Jean REMY
Perpignan HospitalÂ
France

Stephane Montabone
Perpignan HospitalÂ
France

Nathalie Rivard
Professor, UniversitÃ© de SherbrookeÂ
Canada

Ahmed Zaki Helaly
Department of Gastroenterology Alexandria UniversityÂ
Egypt

Baris Cankaya
Marmara University Medical Faculty Training HospitalÂ
Turkey

Nagendra Prasad
Maxcure HospitalsÂ
India

Hemant Atri
Fortis Escorts HospitalÂ
India

Asma Shabbir
Jinnah Sindh Medical University
Pakistan

Mohammad Hayssam Elfawal
Bariatric Surgery ClinicÂ
Lebanon

Muhammad S Niam
Chairman of Indonesian Society of General Surgery Brawijaya University School of Medicine
Indonesia

Amin El-Gohary
Burjeel Hospital
UAE

Azra Husic-Selimovic
University Clinical Center SarajevoÂ
Bosnia and Herzegovina

Khalil N Bitar
Wake Forest School of Medicine Winston SalemÂ
USA

Garima Mittal
SRHU
India

Vani Malhotra
PGIMSÂ
India

Huang Jiwei
Sichuan University
China

Birute Titova
Vilnius University Santariskiu HospitalÂ
Lithuania

Edita Kazenaite
Vilnius Santariskiu clinicsÂ
Lithuania

Jolita Jakutiene
Vilnius University Santariskiu HospitalÂ
Lithuania

Vince Fragomeli
Nepean HospitalÂ
Australia

Ulysses Fagundes Neto
Federal University of SÃ£o Paulo (UNIFESP)
Brazil

Chiou-Hwa Yuh
National Health Research InstitutesÂ
Taiwan

Ali Mahzari
RMIT UniversityÂ
Australia

David H. Van Thiel
Rush Oak Park Hospital & Rush University Medical Center USA
USA

Bashar Attar
Rush University Medical Center USA
USA

Kamal D. Mehta
The Ohio State University College of Medicine USA
USA

Fong-Fong Chu
Henan University of Science and Technology USA
USA

Bruce D Given
Arrowhead Pharmaceuticals, USA
USA

Jay-lin Jane
Iowa State University USA
USA

Robert Rahimi
Baylor Scott and White Liver Consultants of Texas USA
USA

Marco Patti
University of North Carolina at Chapel Hill School of Medicine USA
USA

William J. Rowe
Medical University of Ohio at Toledo, USA
USA

YAZAN ABU QWAIDER
Texas Tech University Health Sciences Center, USA
USA

Carmen Cuffari
Johns Hopkins University,USA, USA
USA

Robert D. Odze
Gastrointestinal Pathology Brigham and Womens Hospital, USA
USA

Pawan Mathur
Royal Free London NHS Fundation Trust, UK
UK

Dimitar tonev
Senior medical director, UK
UK

Tommaso Zurleni
Hospital of Busto Arsizio, Italy
Italy

Antonio Iannetti
University â€œLa Sapienzaâ€ Roma, Italy
Italy

Pierluigi Fracasso
Secretary of the European Society of Primary Care Gastroenterology An affiliate of the Italian Association of Primary Care Gastroenterology., Italy
Italy

Mostafa Shalaby
University of Rome Tor Vergata & Mansoura University, Italy
Italy

Giovanni Gasbarrini
"Vice-President of the International Association of Surgeons & Gastroenterologists founder and President of the "Club del Tenue"., Italy
Italy

Wolfgang Fischbach
Hospital Aschaffenburg-Alzenau., Germany
Germany

Walee Chamulitrat
University Heidelberg, Germany
Germany

Davor Stimac
Rijeka Clinical Hospital Center, Croatia
Croatia

Jessica Danaher
Royal Melbourne Institute of Technology University, Australia
Australia

Ulysses Fagundes Neto
Federal University of SÃ£o Paulo (UNIFESP), Brazil
Brazil

Lynnette Ferguson
University of Auckland School of Medicine, Newzealand
Newzealand

LÃ¡szlÃ³ HerszÃ©nyi
Hungarian Society of Gastroenterology, Hungary
Hungary

Magdy El-Salhy
Bergen University, Norway
Norway

Errawan Wiradisuria
Indonesian Society of Endolaparoscopic Surgeons (ISES), Indonesia
Indonesia

Eduardo LondoÃ±o-Schimmer
American Society of Colon and Rectal Surgeons, Colombia
Colombia

CÃ©line Tiffon
University Hospital Bern, Switzerland
Switzerland

Oleksandr Babii
Institute of Gastroenterology of National Academy Medical Science, Ukraine
Ukraine

Digestive Diseases 2020

It is our great pleasure to invite you to participate in the '5^th International Conference on Digestive and Metabolic Diseases' (Digestive Diseases 2020 Webinar) which will be held during 23^rd -24^th November 2020

Digestive Diseases 2020 Webinar is to bring together global researchers, professors, doctors, scientists, gastroenterologists, hepatologists, diabetologists, endoscopists, internists, physicians, microbiologists, virologists, pathologists, oncologists, surgeons and toxicologists, students, business delegates and young researchers across the globe to voice their examination discoveries to the world to learn about current and upcoming issues, explore new developments in the field of Digestive Diseases and interact with others with similar interest.

The conference themes will include the following topics:

Advancements in Digestive Disease Treatment, Gastrointestinal Oncology, Liver diseases & Transplantation, Micro biome in Gastrointestinal & Liver, Gallstones, Inflammatory Bowel Disease, Haemorrhoids, Colorectal Disease, Gastrointestinal Disorders, Symptoms & Drug delivery, Genetics and Molecular Biology in Gastroenterology, Paediatric Gastroenterology, Pancreatic Cancer, Diseases and Treatments, Diabetic Ketoacidosis, Acid Related Diseases, Gastrointestinal Endoscopy, Neurogastroenterology and Motility.

This meeting will allow the attendees to acquire these new updates and share their experiences with well-recognized speakers globally.

Digestive Diseases 2020 Webinar is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Digestive and Metabolic Diseases.

Young Research’s Awards at Digestive Diseases 2020 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Digestive Diseases 2020.

YRF Registration Benefits:

Young Scientist Award recongination certificate and memento to the winners
Digestive Diseases 2020 Webinar provides best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Provide an opportunity for research interaction and established senior investigators across the globe in the field of Digestive and Metabolic Diseases Webinar.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

YRF Registration Deadline

Till August 30 – $399
Till September 30 – $499
Till October 28 – $599

â€‹Why to attend?

With members from around the world focused on learning about Digestive Diseases Webinar, Metabolic Diseases Webinar and its advances in making a better health; this is your best opportunity to reach the largest assemblage of participants from the Digestive Diseases Webinar and Gastrology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, new treatment techniques and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Digestive Diseases and Gastrology are hallmarks of this conference.

Advantage from updates and bits of knowledge on the most recent government Digestive and Metabolic Diseases procedure and in addition recommendations for guaranteeing best practice and enhancing results.
Associate with more than 200 amazing representatives who are included in Digestive and Metabolic Diseases, issue settle shared difficulties and gain from the broad experience of others.
Attend a variety of informative seminars, engaging interactive presentations, and keynote panel discussions with key policy makers and experts in Didestive and Metabolic Diseases.

5 GOOD REASONS TO ATTEND THIS CONFERENCE

Latest science and developments
International leading experts at your fingertip
Communication among colleagues
Showcase your latest research
New ways of knowledge transfer

Who to attend the conference?

Target Audience

Associations and Societies
Business Entrepreneurs
Case Managers
Claims/Risk Managers
Clinical Nurse Specialists
Data Management Companies
Hospital Administrators
Hospital General Counsel
Legal Nurse Consultants
Manufacturing Medical Devices Companies
Medical Colleges
Digestive Diseases Faculty
Gastrology Nurses/Nurse Practitioners
Nutritionists
Digestive Diseases Researchers
Digestive Diseases Specialists
Gstrologists
Nurses
Digestive Diseases Physicians
Gastrology Physicians
Digestive and Metabolic Diseases Specialists
Gastrology Nurses/Nurse Practitioners
Physician Assistants
Researchers
Residents
Software developing companies
Training Institutes
Young researchers

Track 1: Advancements in Digestive Disease Treatment

Progression in the analysis and treatment of gastrointestinal diseases has been outstanding in the running years. Examination is going on new diagnostic strategies and novel therapeutic frameworks for gastroesophageal reflux sickness (GERD), pancreatic-biliary and post-surgical issues, Barrett's throat, neuroendocrine tumours and gastrointestinal stromal tumours. In Japan, gastric development is the second driving purpose behind threat passing.

Relevant Conferences:

16^th International Conference on Gastroenterology & Hepatology July 20-21, 2020 Webinar; International Conference on Digestive and Gastroenterology Health Conditions July 20-21, 2020 Webinar; 5^th International Conference on Digestive and Metabolic Diseases November 23-24, 2020 Webinar; 16^th World Congress on Gastroenterology & Therapeutics April 06-07, 2020 Webinar; 2^nd International Conference on Digestive Disease June 22-23, 2020 Webinar; 14^thInternational Conference on Endocrine and Metabolic Diseases August 20-21, 2020 in Webinar;

Relevant Societies:

USA: American College of Gastroenterology |GI Diseases conferences | American Gastroenterological Association (AGA) | Digestive Disorders Conference | Digestive Disorders Conferences 2020 | North American Society for Paediatric Gastroenterology | Hepatology and Nutrition (NASPGHAN) | NEW YORK Society For Gastrointestinal Endoscopy( NYSGE) | Gastroenterology conferences 2020 South Florida Gastroenterology Associates, P.A | Digestive Disorders Conference | Ohio Gastroenterology Society (OGS) | American Gastroenterological Association (AGA) | Digestive Disorders Conference | Hepatology conferences | North American Society for Paediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) | Digestive Disorders | NEW YORK Society For Gastrointestinal Endoscopy( NYSGE)

Track 2: Gastrointestinal Oncology

Gastrointestinal disease alludes to dangerous states of the gastrointestinal tract (GI tract) and embellishment organs of processing, including the throat, stomach, biliary framework, pancreas, small digestive system, internal organ, rectum and anus. The symptoms are associated to the damaged organ and can include obstruction (leading to difficulty swallowing or defecating), abnormal bleeding or other related problems. The finding regularly requires endoscopy, trailed by biopsy of suspicious tissue. The treatment relies upon the area of the tumour, and additionally the kind of disease cell and whether it has attacked different tissues or spread somewhere else. These components likewise decide the guess.

Relevant Conferences:

Relevant Societies:

Track 3: Liver diseases & Transplantation

Liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Indications of liver sickness can differ, however they frequently incorporate swelling of the abdomen and legs, bruising easily, changes in the shade of your stool and urine. The first attempted human liver transplant was performed in 1963 by Dr. Thomas Starzl, although the paediatric patient died intra operatively due to uncontrolled bleeding. In spite of the improvement of suitable surgical procedures, liver transplantation stayed trial through the 1970s, with one year tolerant survival in the region of 25%. Liver transplantation is now performed at over one hundred centers in the US, as well as numerous centres in Europe and elsewhere.

Relevant Conferences:

Relevant Societies:

Track 4: Micro biome in Gastrointestinal & Liver

The micro biome comprises all of the genetic material within a micro biota (the entire collection of microorganisms in a specific niche, such as the human gut). This can also be referred to as the metagenome of the micro biota. Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Here we characterize the gut micro biome in liver cirrhosis by comparing 98 patients and 83 healthy control individuals. We manufacture a reference gene set for the accomplice containing 2.69 million genes, 36.1% of which are novel. Quantitative metagenomics reveals 75,245 genes that differ in abundance between the patients and healthy individuals (false discovery rate < 0.0001).

Relevant Conferences:

Relevant Societies:

Track 5: Gallstones

They aren't generally stones. They're bits of strong material that shape in the gallbladder, a little organ situated under the liver. You won't not know you have them until the point that they obstruct a bile pipe, causing torment that you have to escape. The two fundamental sorts are: Cholesterol stones, Pigment stones.

Relevant Conferences:

Relevant Societies:

Track 6: Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) represents a group of intestinal disorders that cause prolonged inflammation of the digestive tract. The digestive tract comprises the mouth, oesophagus, stomach, small intestine, and large intestine. It’s responsible for breaking down food, extracting the nutrients, and removing any unusable material and waste products. Inflammation anywhere along the digestive tract disrupts this normal process. IBD can be very painful and disruptive, and in some cases, it may even be life-threatening.

Relevant Conferences:

Relevant Societies:

Track 7: Haemorrhoids

Haemorrhoids (HEM-uh-roids), also called piles, are swollen veins in your anus and lower rectum, similar to varicose veins. Haemorrhoids have a number of causes, although often the cause is unknown. They may result from straining during bowel movements or from the increased pressure on these veins during pregnancy. Haemorrhoids may be located inside the rectum (internal haemorrhoids), or they may develop under the skin around the anus (external haemorrhoids).

Relevant Conferences:

Relevant Societies:

Track 8: Colorectal Disease

Together the colon and rectum make up our large intestine; they each play separate and important roles in our digestive process. For that reason, medical disorders that affect this area of the body may be called “colorectal” or “intestinal” disorders. Colorectal conditions range from common and often treatable problems such as chronic constipation, to rare or life-threatening disorders including anal cancer.

Relevant Conferences:

Relevant Societies:

Track 9: Gastrointestinal Disorders, Symptoms & Drug delivery

Gastrointestinal motility is characterized by the movements of the digestive system, and the transit of the contents within it. Gastrointestinal Disorder is the disorder related to gastrointestinal tract namely the oesophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Gastrointestinal disorders include such conditions as constipation, irritable bowel syndrome, haemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer.

Relevant Conferences:

Relevant Societies:

Track 10: Genetics and Molecular Biology in Gastroenterology

Molecular biology has become an integral part of basic and clinical gastroenterology. A broad spectrum of infectious, inherited and malignant gastrointestinal diseases can now be studied by molecular methods, including polymerase chain reaction, hybridization and DNA sequence analyses. At recent progress in the molecular analysis of Whipple's disease and colorectal cancer, two major problems in clinical gastroenterology. Genetics have led to an increased understanding of the genetic determinants of gastrointestinal disorders.

Relevant Conferences:

Relevant Societies:

Track 11: Paediatric Gastroenterology

Paediatric gastroenterologists treat children from the new born period through the teen years. Kids are developing and have remarkable therapeutic needs. They can't generally answer therapeutic inquiries and are not generally ready to be patient and helpful. Paediatric gastroenterologists know how to analyse and treat youngsters in a way that makes them casual and agreeable. The aim of the study of paediatric gastroenterology is to reduce infant and child rate of deaths, control the spread of infectious disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents.

Relevant Conferences:

Relevant Societies:

Track 12: Pancreatic Cancer, Diseases and Treatments

Issues with the pancreas can prompt numerous medical issues like Pancreatitis, when stomach related chemicals begin processing the pancreas itself, pancreatic cancer, Cystic fibrosis it is a hereditary issue in which thick, sticky bodily fluid can likewise square tubes in your pancreas. The pancreas additionally assumes a part in diabetes.

Relevant Conferences:

Relevant Societies:

Track 13: Diabetic Ketoacidosis

It is a life threatening problem and needs awareness about its prevention. It occurs when body doesn’t produce enough insulin and body cells can’t use sugar in blood for energy then body start using fat as fuel for energy. When the body continue to burn fat, it makes acids called ketones. If this process remains continue for a period of time, it will build up in body and can change the chemical balance of body and will affect the whole body functions. It is seen more in young ones having type 1diabetes.

Relevant Conferences:

Relevant Societies:

Track 14: Acid Related Diseases

This is divided into 7 sections : the production of acid in the stomach, the regulation of gastric acid secretion, the pharmacology of acid secretion, the biology of acid-related diseases, gastric and duodenal ulcer disease, gastro oesophageal reflux disease, and Helicobacter pylori. Each of these sections is extremely well written and provides historical insights into the various areas. For example, the first section point out that Paracelsus was one of the first to relate chemistry to disease; however, he was under the mistaken assumption that acid found in the stomach was ingested.

Section 2 presents an accounting of William Beaumont’s study of the gastric fistula in Alexis Saint Martin, which was the result of a gunshot wound. Also included in this section is the accounting of Pavlov’s delineation of vagal function in relation to the GI tract. Other important milestones of gastric physiology that are recounted include Codes’ study of the relationship of histamine to gastric secretion and the work of Bayless and Starling in identifying the hormone secretin.

In Section 2, gastric acid secretion and its neural and endocrine regulation is covered in a comprehensive manner as are all aspects of parietal cell function.

The history of the therapeutic approach to acid-related diseases is detailed in Section 3 and includes the Sippy diet, antacids, sulphated polysaccharide (sulcralfate), histamine H2 receptor antagonists, and proton pump inhibitors along with surgery.

Section 4 deals with the barrier function of the upper GI tract, intra gastric pH, pepsin, intrinsic factor, and regulation of the growth of gastric epithelium.

The final section deals with Helicobacter pylori and covers its well-known history and the consequences of gastric colonization along, with the pathogenesis and treatment options

Relevant Conferences:

Relevant Societies:

Track 15: Gastrointestinal Endoscopy

Gastrointestinal endoscopy is a technique that enables your specialist to take a gander at within covering of your throat your stomach, and the initial segment of your small digestive tract. A thin, adaptable review apparatus called an endoscope (scope) is utilized. The tip of the extension is embedded through your mouth and after that tenderly moved down your throat into the throat, stomach and duodenum (upper gastrointestinal tract). In patients with OGIB, upper and lower GI tract endoscopies regularly are rehashed before little gut assessment because significant starting endoscopic miss rates have been accounted for.

Relevant Conferences:

Relevant Societies:

Track 16: Neurogastroenterology and Motility

Normal contractions of the gut (called peristalsis) move food down the intestinal tract from the oral cavity to the rectum and facilitate absorption of nutrients. These peristaltic contractions occur when the muscle layers of the gut and the nerves embedded in them work together in a synchronized manner. Motility disorders of the gut can occur in association with abnormalities in other organ systems such as the central nervous system, mitochondrial disorders, muscular dystrophies and others. Neurogastroenterology helps in the comprehension of the elements of the parasympathetic, thoughtful, and enteric divisions of the gastrointestinal tract. Neurons are available on each surface of our body. It is because of these neurons that we feel and can do of the deliberate and automatic activities. So also, neurons are likewise found on the gastrointestinal surfaces. It is because of these neurons that we can swallow the nourishment, and which is then taken to the distinctive organs for their working, which thus is again organized by the cerebrum.

Parasympathetic division
Gastrointestinal Motility
Thoughtful division
Enteric division
Peristaltic reflex

Relevant Conferences:

Relevant Societies:

Digestive and Metabolic diseases 2020 Market Analysis

Description:

Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. Chemicals in human digestive system break the food parts down into sugars and acids. Metabolic disorders occur when abnormal chemical reactions in human body disturb this process. This is due to enzyme deficiency: as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder.

While in 2015, the market size of metabolic disorder therapeutics was valued over USD XX million. The global metabolic disorder therapeutics market is projected to grow with a CAGR between 4.8% and 5.3% over the forecast period of 2018-2023 and reach USD 200 billion by 2023.

Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. This is due to enzyme deficiency as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder.

Increase in academia-industry collaborations for drug developments is the key factor responsible for the growth of metabolic disorder therapeutics market. Furthermore, growing diabetic population is significantly contributing to the growth of this market. Low compliance, adherence rate for metabolic disorder therapies and availability of alternative treatment option are the major challenges faced by the players operating in this market. The global metabolic disorder therapeutics market is anticipated to present several opportunities of growth of market size over the forecast period due to strategic collaborations and acquisition and increased R & D investment.

Market Insights

Segment Covered

The report on global metabolic disorders therapeutics market covers segments such as, disease type and product. On the basis of disease type the global metabolic disorders therapeutics market is categorized into diabetes, obesity, hypercholesterolemia and lysosomal storage disease. On the basis of product the global metabolic disorders therapeutics market is categorized into metachromatic leukodystrophy, globoid leukodystrophy,hepatic encephalopathy and others.

The report segments the metabolic disorder therapeutics market by types of disease and by region. Among segments given above; diabetes market is estimated to be 24.9 billion USD in 2017, it is growing because of the higher growth in the global type 2 diabetic population. The Oral Anti Diabetes Market is expected to witness a growth of about 28% from 2018 to 2023 and it is expected to reach USD 34.1 billion by 2023.The increasing diabetic population across the globe is one of the significant factors propelling the growth of this segment.

Gastroenterology in America:

Over the review period in America, the changing lifestyles of consumers resulted in a significant increase in dietary ailments that are reflected in the positive performance of digestive remedies. According to the market analysis, digestive disorders affect more than 20 million people each year. Inflammatory bowel disease (IBD), heartburn, acid reflux and irritable bowel syndrome (IBS) are among the most common digestive disorders.

Gastroenterology in Asia:

Though the Asia-Pacific market for probiotics is globally the largest, accounting for an estimated share of 38% in 2018, market maturity is expected to curtail growth prospects over the coming years, with other regions taking the lead. Within Asia-Pacific, Japan forms the largest probiotics market, with an estimated share of 45% in 2018. However, growth in demand for probiotics is likely to be the fastest in China, with a forecast CAGR of about 13.2% between 2017 and 2023. By segment, human applications such as dietary supplements, functional foods & beverages and specialty nutrients dominate the probiotics market in the region. expected to grow at a CAGR of 6.6% over the forecast period.

Top Universities across the world:

1. University of Oxford

2. Stanford University

3. University of Cambridge

4. Harvard University

5. Princeton University

6. Imperial College London

7. ETH Zurich – Swiss Federal Institute of Technology Zurich

Associations/Societies across the world:

1. American Gastroenterological Association

2. World Gastroenterology Organisation

3. Ontario Association of Gastroenterology

4. Canadian Association of Gastroenterology

5. United European Gastroenterology

6. Florida Gastroenterological Society

Top universities in London:

1. University College London (UCL)

2. Imperial College London

3. King's College London

4. Queen Mary, University of London

5. Royal Holloway, University of London

6. Birkbeck College, University of London

7. City, University of London

8. Brunel University

Associations/Societies in London:

1. British Society of Gastroenterology (BSG)

2. London Gastrointestinal Associates

3. Association of upper Gastrointestinal Surgeons of Great Britain

4. The Royal Society of Medicine

5. Associations of Medical Research Charities

Geographic Coverage and Analysis:

North America was the largest market for metabolic disorder and likely to continue its dominance with a majority market shares globally over the period of 2017 to 2023. The US was the major contributor in the region, as half of the adult population in the country is suffering from diabetes over past couple of years. Following North America, Asia Pacific accounted to be the most prominent region for metabolic disorder over the forecast period. Healthcare reforms across the region and rising diabetic population especially in India are anticipated to boost the growth in the Asia - Pacific market.

Attribute	Details
Base year for estimation	2017
Review Period	2012-2017
Forecast Period	2018 – 2023
Market Representation	Revenue in USD billion and CAGR from 2018 – 2023
Regions covered	North America, Europe, Asia-Pacific, Middle East and Africa and Latin America
Report coverage	Revenue forecast, market share analysis, and market dynamics

Report highlights

In addition, this report provides insights on the factors that are driving and restraining the global demand of metabolic disorders therapeutics globally as well as regionally.

We also have highlighted future trends in the metabolic disorders therapeutics market that will impact the demand during the forecast period.This report will help manufacturers, suppliers and distributors of the metabolic disorders therapeutics market to understand the present analysis.

The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of metabolic disorders therapeutics market the study highlights current market trends and provides forecast from 2017-2023

We also have highlighted future trends in the metabolic disorders therapeutics market that will impact the demand during the forecast period

This report will help manufacturers, suppliers and distributors of the metabolic disorders therapeutics market to understand the present and future trends in this market and formulate their strategies accordingly.

Top Companies Profile:

The companies covered in the report include:

-Novo Nordisk
-Sanofi
-Merck
-AstraZeneca
-EliLily
-AbbVie
-Actelion Pharmaceuticals
-Amicus Therapeutics
-Arena Pharmaceuticals
-Astellas Pharma
-Biocon
-Biospheres
-Boehringer Ingelheim
-CKDBio
-Concord Biotech
-ConjuChem
-CureDm
-CymaBay Therapeutics
-Daewoong
-Daiichi Sankyo
-Dance Biopharm

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 23-24, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

5^th International Conference on Digestive and Metabolic Diseases November 23-24, 2020 London, UK

Recommended Global Gastroenterology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Digestive Diseases 2020

Conference Highlights

To Collaborate Scientific Professionals around the World

Association with

Useful Links

Special Issues